Today's Information |
Provided by: All Cosmos Bio-Tech Holding Corporation | |||||
SEQ_NO | 1 | Date of announcement | 2022/07/13 | Time of announcement | 19:29:37 |
Subject | The board of directors of the company resolved to issue the first unsecured domestic convertible corporate bonds | ||||
Date of events | 2022/07/13 | To which item it meets | paragraph 11 | ||
Statement | 1.Date of the board of directors resolution:2022/07/13 2.Name [issue no.__ of (secured, unsecured) corporate bonds of ___________ (company)]: All Cosmos Bio-Tech Holding Corporation The first unsecured domestic convertible corporate bonds 3.Whether to adopt shelf registration (Yes/No):No 4.Total amount issued: The total denomination of the issue is NT$500 million 5.Face value per bond: NT$100,000 6.Issue price: Issued at 101%~101.5% of the face value 7.Issuance period:Three years 8.Coupon rate: The coupon rate is 0% per annum 9.Types, names, monetary values and stipulations of collaterals: Not applicable 10.Use of the funds raised by the offering and utilization plan: Replenish working capital 11.Underwriting method: Underwriter will make public sales by way of enquiry and encirclement 12.Trustees of the corporate bonds: Authorize the chairman of the board to deal with it 13.Underwriter or agent: Authorize the chairman of the board to deal with it 14.Guarantor(s) for the issuance: It is an unsecured domestic convertible corporate bonds, so it is not applicable. 15.Agent for payment of the principal and interest: Authorize the chairman of the board to deal with it 16.Certifying institution: It is the issue of intangible securities so it is not applicable 17.Where convertible into shares, the rules for conversion: Relevant measures will be handled in accordance with relevant laws and regulations, and will be reported to the relevant competent authorities for approval and announced separately 18.Sell-back conditions: Relevant measures will be handled in accordance with relevant laws and regulations, and will be reported to the relevant competent authorities for approval and announced separately 19.Buyback conditions: Relevant measures will be handled in accordance with relevant laws and regulations, and will be reported to the relevant competent authorities for approval and announced separately 20.Reference date for any additional share exchange, stock swap, or subscription: Relevant measures will be handled in accordance with relevant laws and regulations, and will be reported to the relevant competent authorities for approval and announced separately 21.Possible dilution of equity in case of any additional share exchange, stock swap, or subscription: Relevant measures will be handled in accordance with relevant laws and regulations, and will be reported to the relevant competent authorities for approval and announced separately 22.Any other matters that need to be specified: 1.Due to the rapid changes in the financing environment of the capital market, in order to grasp the time limit for setting the issuance conditions and the actual issuance operation, the content of this first issued domestic unsecured convertible corporate bond, including issue time, issue amount, issue price, issue conditions, issuance and conversion methods related to the conversion of corporate bonds, projects for the funds, the source of funds, the progress of the use of funds,the expected benefits and other related matters, if instructed by the competent authority, relevant laws and regulations are amended, or when the objective environment needs to be revised or amended authorize the chairman of the board to deal with it. 2.In order to handle this fund raising operation, it is proposed to authorize the chairman of the board to sign all relevant contracts and documents on behalf of the company, and to fully handle the unfinished matters |
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
All Cosmos Bio-Tech Holding Corporation published this content on 13 July 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 13 July 2022 11:33:00 UTC.